Clinical Trials Directory

Trials / Completed

CompletedNCT03712917

Comparison of Therapeutic Effects of Greater Occipital Nerve Block, Topiramate, and Flunarizine on Episodic Migraine

Comparison of Therapeutic Effects of Greater Occipital Nerve Block, Topiramate, and Flunarizine on Episodic Migraine: A Randomised Parallel Group Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Ataturk University · Academic / Other
Sex
All
Age
15 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Background: Preventive drug therapy in migraine aims to reduce the attack frequency, severity and duration of headache. Flunarizine and topiramate are widely used in the prevention of migraine attacks. Greater occipital nerve block (GONB) is an alternative treatment option for the prophylactic treatment of migraine. In this study, investigators compared the effectiveness of GONB, topiramate, and flunarizine in terms of reduction in post-treatment VAS scores and attack frequencies in patients with episodic migraine in a four-week period. Material and Methods: At least one hundred and twenty migraine patients are aimed to be randomly divided into three treatment groups, namely flunarizine (n=40, estimated), topiramate (n=40, estimated) and GONB (n=40, estimated). The patients will be followed up for four weeks and the attack frequencies and VAS scores will be recorded weekly. At the end of the fourth week, the response rates based on 50% and 75% or more reduction in the VAS scores and attack frequencies will be calculated. Group-wise comparisons will be assessed statistically.

Conditions

Interventions

TypeNameDescription
PROCEDUREGreater Occipital Nerve BlockAn enjection to paralyze the occipital nerve.
DRUGTopiramateAn antiepileptic agent used for migraine prophylaxis.
DRUGFlunarizineA calcium overload blocker agent used for migraine prophylaxis.

Timeline

Start date
2019-03-01
Primary completion
2019-03-31
Completion
2019-03-31
First posted
2018-10-19
Last updated
2020-01-21
Results posted
2020-01-21

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03712917. Inclusion in this directory is not an endorsement.